A certified analytics engine
CE Class IIa ECG analytics for resting, Holter and wearable recordings, from 1 to 12 leads.
Research & Development
Cardiolyse works with university hospitals, research groups and industry on ECG-derived biomarkers, algorithm co-development and clinical validation — bringing a CE Class IIa analytics engine, hundreds of ECG parameters and more than ten years of ECG research.
Partners bring the clinical question, the cohort and the outcomes. Cardiolyse brings the ECG analysis, the engineering and the validation experience.
CE Class IIa ECG analytics for resting, Holter and wearable recordings, from 1 to 12 leads.
Rhythm, morphology, intervals, HRV metrics and composite scores for every recording, as structured data.
Screen ECG-derived markers against your outcomes to find the ones that predict disease and progression.
Develop and tune algorithms with your clinical team for a new indication, device or population.
Design and run validation studies, retrospective or prospective, with methods ready for publication.
GDPR-aligned processing and ISO 27001-aligned security, with pseudonymised data wherever possible.
Each collaboration answers a different question — from outcome prediction to workflow in a hospital setting.

Clinical validation
The Risk of Heart Disorders score predicted worsening heart failure and all-cause death, independently of NT-proBNP and the MAGGIC score.
Read the study
Hospital pilot
Taken through TheHill Oxford’s formal pipeline to pilot stage at the John Radcliffe Hospital, with one of OUH’s leading cardiologists.
Read the case
Clinical pilot
Post-ablation patients followed at home for twelve weeks, with the arrhythmology and electrophysiology team assessing the workflow.
Read the caseWe define the clinical question, the cohort, the outcomes and the ECG data together.
ECG recordings are shared under an agreed data protection framework, pseudonymised where possible.
Cardiolyse processes the recordings and delivers ECG parameters and scores as structured data.
Your team links the results to outcomes. We support the statistics, methods and publication.
Run Cardiolyse analytics on an existing ECG cohort and link the parameters to outcomes you already hold.
Build or adapt an algorithm for a new indication or device, with shared milestones and validation.
Join a national or EU-funded project as the ECG analytics partner. See EU Projects.
University hospitals, research groups, CROs and industry partners. Recent work includes the University Medical Center Mainz, Oxford University Hospitals and GVM Care & Research.
Yes. For research, results are delivered as structured data with the ECG parameters and scores in scope, ready for your statistical analysis.
Ownership, publication rights and data use are agreed in the collaboration agreement before the work starts.
Yes. Cardiolyse regularly joins consortia as the ECG analytics and validation partner. See EU Projects for current interests.
Data is processed under GDPR-aligned terms with ISO 27001-aligned security, and pseudonymised wherever the study allows.
For everything else, see the full FAQ.
Tell us about the cohort and the outcome. We will suggest how Cardiolyse can contribute.